vs
Side-by-side financial comparison of Farmland Partners Inc. (FPI) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $20.7M, roughly 1.5× Farmland Partners Inc.). Farmland Partners Inc. runs the higher net margin — 103.4% vs -32.1%, a 135.5% gap on every dollar of revenue. On growth, Farmland Partners Inc. posted the faster year-over-year revenue change (-3.5% vs -4.5%). Over the past eight quarters, Farmland Partners Inc.'s revenue compounded faster (31.4% CAGR vs -0.1%).
Farmland Industries was the largest agricultural cooperative in North America when it eventually sold all of its assets in 2002–04. During its 74-year history, Farmland served its farmer membership as a diversified, integrated organization, playing a significant role in agricultural markets both domestically and worldwide.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
FPI vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $20.7M | $31.1M |
| Net Profit | $21.4M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | — | -9.9% |
| Net Margin | 103.4% | -32.1% |
| Revenue YoY | -3.5% | -4.5% |
| Net Profit YoY | -63.5% | -52.0% |
| EPS (diluted) | $0.44 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.7M | — | ||
| Q3 25 | $11.3M | $31.1M | ||
| Q2 25 | $10.0M | — | ||
| Q1 25 | $10.3M | $35.2M | ||
| Q4 24 | $21.5M | $32.6M | ||
| Q3 24 | $13.3M | $24.7M | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $12.0M | $35.7M |
| Q4 25 | $21.4M | — | ||
| Q3 25 | $483.0K | $-10.0M | ||
| Q2 25 | $7.6M | — | ||
| Q1 25 | $2.0M | $-14.8M | ||
| Q4 24 | $58.7M | $-6.6M | ||
| Q3 24 | $1.8M | $-16.2M | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $1.4M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | — | — | ||
| Q3 25 | 4.3% | -9.9% | ||
| Q2 25 | 78.2% | — | ||
| Q1 25 | 20.6% | -25.7% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | 13.9% | -46.9% | ||
| Q2 24 | -17.9% | — | ||
| Q1 24 | 11.9% | -2.5% |
| Q4 25 | 103.4% | — | ||
| Q3 25 | 4.3% | -32.1% | ||
| Q2 25 | 76.3% | — | ||
| Q1 25 | 19.9% | -42.0% | ||
| Q4 24 | 273.6% | -20.2% | ||
| Q3 24 | 13.5% | -65.7% | ||
| Q2 24 | -17.5% | — | ||
| Q1 24 | 11.5% | 43.8% |
| Q4 25 | $0.44 | — | ||
| Q3 25 | $0.00 | $-0.29 | ||
| Q2 25 | $0.14 | — | ||
| Q1 25 | $0.03 | $-0.47 | ||
| Q4 24 | $1.09 | $-0.25 | ||
| Q3 24 | $0.02 | $-0.53 | ||
| Q2 24 | $-0.06 | — | ||
| Q1 24 | $0.01 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $18.9M |
| Total DebtLower is stronger | $161.6M | $136.0M |
| Stockholders' EquityBook value | $467.4M | $-10.5M |
| Total Assets | $719.1M | $235.2M |
| Debt / EquityLower = less leverage | 0.35× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $161.6M | — | ||
| Q3 25 | $170.4M | $136.0M | ||
| Q2 25 | $193.4M | — | ||
| Q1 25 | $202.6M | $124.9M | ||
| Q4 24 | $204.6M | $111.3M | ||
| Q3 24 | $394.0M | $106.3M | ||
| Q2 24 | $393.0M | — | ||
| Q1 24 | $383.0M | $97.1M |
| Q4 25 | $467.4M | — | ||
| Q3 25 | $457.3M | $-10.5M | ||
| Q2 25 | $473.5M | — | ||
| Q1 25 | $492.2M | $2.2M | ||
| Q4 24 | $494.6M | $15.4M | ||
| Q3 24 | $519.4M | $-3.9M | ||
| Q2 24 | $521.5M | — | ||
| Q1 24 | $526.7M | $17.7M |
| Q4 25 | $719.1M | — | ||
| Q3 25 | $738.5M | $235.2M | ||
| Q2 25 | $776.7M | — | ||
| Q1 25 | $810.5M | $237.7M | ||
| Q4 24 | $869.6M | $255.4M | ||
| Q3 24 | $1.0B | $246.8M | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $1.0B | $246.2M |
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.41× | 56.05× | ||
| Q4 24 | 0.41× | 7.20× | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 0.73× | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.4M | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 0.81× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.4M | — | ||
| Q3 25 | $-2.0M | $1.8M | ||
| Q2 25 | $-2.2M | — | ||
| Q1 25 | $6.4M | $1.2M | ||
| Q4 24 | $16.1M | $-6.1M | ||
| Q3 24 | $-4.3M | $-613.0K | ||
| Q2 24 | $-6.1M | — | ||
| Q1 24 | $11.9M | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.8% |
| Q4 25 | 0.81× | — | ||
| Q3 25 | -4.04× | — | ||
| Q2 25 | -0.29× | — | ||
| Q1 25 | 3.12× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | -2.39× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 8.66× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FPI
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
